The FDA today approved Abbott’s catheter-based MitraClip device for patients with significant symptomatic degenerative MR who are at prohibitive risk for mitral valve surgery. The company said it would launch the device immediately in the United States. The device is the first percutaneous nonsurgical therapy approved for the treatment of mitral valve disease. … Click here…
FDA Approves Abbot’s MitraClip For Patients At Prohibitive Surgical Risk
October 25, 2013 by Leave a Comment
Two Trials Explore On-Pump Versus Off-Pump Bypass Surgery
March 11, 2013 by Leave a Comment
Two large trials presented at the American College of Cardiology meeting in San Francisco and published simultaneously in the New England Journal of Medicine provide important new information about the ongoing debate over whether CABG should be performed with or without cardiopulmonary bypass. The combined results suggest that both techniques can be effective, and that surgeons…
Recent Comments